XIFAXAN® 550 mg
PRESCRIPTION MEDICINE
XIFAXAN® 550 mg is the brand name for the medicine rifaximin. XIFAXAN® 550 mg is indicated for “Prevention of the recurrence of hepatic encephalopathy where other treatments have failed or are contraindicated”.
XIFAXAN® 200 mg
PRESCRIPTION MEDICINE
XIFAXAN® 200 mg (rifaximin) is indicated for the treatment of patients (≥ 12 years of age) with travellers’ diarrhoea caused by non-invasive strains of Escherichia coli.
Product under licence from Alfasigma S.p.A. XIFAXAN is a registered trademark of the Alfasigma group of companies, licensed to the Norgine group of companies.
ANZ-HE-XIF-2000016. Date of Preparation: April 2020
